Guanghui Hu

As a winner of EY Entrepreneur of The Year, Dr. Guanghui Hu is a visionary leader with extensive experience and deep knowledge in entrepreneurship, venture investment, and business management. Dr. Hu has built one of the most innovative and fastest-growing healthcare companies in America, as recognized by both Inc 5000 and Financial Times, and acquired over a decade’s worth of experience in drug discovery and development at Roche, GlaxoSmithKline, and Merck. Dr. Hu completed his postdoctoral research at the University of California at Los Angeles after earning his PhD from Baylor College of Medicine. He also holds an MS degree from the Chinese Academy of Sciences, and a BS degree from Tsinghua University.